Pneumococcal Vaccine Trials in Columbus
Aventiv Research is currently participating in a pneumococcal vaccine study at our Columbus, Ohio location. The flu is a highly contagious and prevalent virus during the winter season. Pneumonia can develop as a complication from the flu and is a serious infection or inflammation of the lungs. Because both illnesses cause many deaths every year, it has become a national health objective to increase vaccination levels, particularly among the elderly. Like any other drug, a new vaccine must be tested on human subjects before being approved for use by the Federal Drug Administration (FDA).
Pneumococcal Vaccine Study
The primary objective of this clinical trial is to evaluate the safety and immunogenicity of an investigational novel pneumococcal vaccine in healthy adults. You may qualify for this study if you’re 50-84 years of age and are:
- A healthy volunteer who is overtly healthy as determined by medical evaluation
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for our Pneumococcal vaccine clinical research study. *Qualified volunteers will be compensated for time and travel.